THE EFFECTS OF TYROSINE ON COGNITIVE PERFORMANCE DURING EXTENDED WAKEFULNESS

被引:1
|
作者
NERI, DF [1 ]
WIEGMANN, D [1 ]
STANNY, RR [1 ]
SHAPPELL, SA [1 ]
MCCARDIE, A [1 ]
MCKAY, DL [1 ]
机构
[1] USN,AEROSP MED RES LAB,PENSACOLA,FL
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Tyrosine, a large neutral amino acid found in dietary proteins, has received recent attention as a potential treatment for stress. The behavioral effects of tyrosine were examined during an episode of continuous nighttime work involving one night's sleep loss. Subjects performed nine iterations of a battery of performance tasks and mood scales for approximately 13 h, beginning at 1930 and ending at 0820. They remained awake throughout the day on which the experiment began and were awake for more than 24 h by the end of testing. Six hours after the experiment began, one-half of the subjects received 150 mg . kg(-1) tyrosine in a split dose while the other half received cornstarch placebo in a double-blind procedure. Tyrosine administration was associated with a significant amelioration of the usual performance decline on a psychomotor task and a significant reduction in lapse probability on a high-event-rate vigilance task. The improvements lasted on the order of 3 h. The results of this study also suggest that tyrosine is a relatively benign treatment at this dose. After further testing with other doses and timing of administration, tyrosine may prove useful in counteracting performance decrements during episodes of sustained work coupled with sleep loss.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [41] Wakefulness and Dreaming: Unusual Events and Their Cognitive Processing During Waking and Dreaming
    Schwerdtle, Barbara
    Haefner, Stefan
    Hobson, J. Allan
    Kuebler, Andrea
    DREAMING, 2016, 26 (02) : 169 - 183
  • [42] EFFECTS OF PROLONGED WAKEFULNESS AND DISTRACTION ON SIMULATED DRIVING PERFORMANCE
    MacLean, A.
    Markell, M.
    York, M.
    SLEEP MEDICINE, 2019, 64 : S238 - S238
  • [43] Influence of circadian phase and extended wakefulness on glucose levels during forced desynchrony
    Broussard, Josiane L.
    Knud-Hansen, Brent C.
    Grady, Scott
    Knauer, Oliver A.
    Ronda, Joseph M.
    Aeschbach, Daniel
    Czeisler, Charles A.
    Wright, Kenneth P., Jr.
    SLEEP HEALTH, 2024, 10 (01) : S96 - S102
  • [44] Dissociation of trait-dependent subjective and objective alertness during extended wakefulness
    Leproult, RD
    Colecchia, EF
    Berardi, AM
    Stickgold, R
    Kosslyn, SM
    Van Cauter, E
    SLEEP, 2002, 25 : A85 - A85
  • [45] Sleep tendency during extended wakefulness: insights into adolescent sleep regulation and behavior
    Taylor, DJ
    Jenni, OG
    Acebo, C
    Carskadon, MA
    JOURNAL OF SLEEP RESEARCH, 2005, 14 (03) : 239 - 244
  • [46] Effects of aging on glucose regulation during wakefulness and sleep
    Frank, SA
    Roland, DC
    Sturis, J
    Byrne, MM
    Refetoff, S
    Polonsky, KS
    VanCauter, E
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (06): : E1006 - E1016
  • [47] COGNITIVE PERFORMANCE DETERIORATES DURING CHRONIC SLEEP RESTRICTION IN THE ABSENCE OF EXTENDED WAKE EPISODES
    Mchill, A.
    Hull, J.
    Wang, W.
    Czeisler, C.
    Klerman, E.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 12 - 12
  • [48] Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment
    Scott Grady
    Daniel Aeschbach
    Kenneth P Wright
    Charles A Czeisler
    Neuropsychopharmacology, 2010, 35 : 1910 - 1920
  • [49] Extended wakefulness alters the relationship between EEG oscillations and performance in a sustained attention task
    Snipes, Sophia
    Meier, Elias
    Accascina, Simon
    Huber, Reto
    JOURNAL OF SLEEP RESEARCH, 2024,
  • [50] Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment
    Grady, Scott
    Aeschbach, Daniel
    Wright, Kenneth P., Jr.
    Czeisler, Charles A.
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (09) : 1910 - 1920